GB9914025D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9914025D0
GB9914025D0 GBGB9914025.3A GB9914025A GB9914025D0 GB 9914025 D0 GB9914025 D0 GB 9914025D0 GB 9914025 A GB9914025 A GB 9914025A GB 9914025 D0 GB9914025 D0 GB 9914025D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914025.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9914025.3A priority Critical patent/GB9914025D0/en
Publication of GB9914025D0 publication Critical patent/GB9914025D0/en
Priority to PCT/GB2000/002304 priority patent/WO2000078742A1/en
Priority to AU54141/00A priority patent/AU5414100A/en
Priority to JP2001504908A priority patent/JP2003502415A/en
Priority to EP00938917A priority patent/EP1192146A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
GBGB9914025.3A 1999-06-17 1999-06-17 Chemical compounds Ceased GB9914025D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9914025.3A GB9914025D0 (en) 1999-06-17 1999-06-17 Chemical compounds
PCT/GB2000/002304 WO2000078742A1 (en) 1999-06-17 2000-06-14 Chroman derivatives against neurological disorders
AU54141/00A AU5414100A (en) 1999-06-17 2000-06-14 Chroman derivatives against neurological disorders
JP2001504908A JP2003502415A (en) 1999-06-17 2000-06-14 Chromane derivatives for neurological disorders
EP00938917A EP1192146A1 (en) 1999-06-17 2000-06-14 Chroman derivatives resisting neurological disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914025.3A GB9914025D0 (en) 1999-06-17 1999-06-17 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9914025D0 true GB9914025D0 (en) 1999-08-18

Family

ID=10855475

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914025.3A Ceased GB9914025D0 (en) 1999-06-17 1999-06-17 Chemical compounds

Country Status (5)

Country Link
EP (1) EP1192146A1 (en)
JP (1) JP2003502415A (en)
AU (1) AU5414100A (en)
GB (1) GB9914025D0 (en)
WO (1) WO2000078742A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3067399B2 (en) * 1992-07-03 2000-07-17 株式会社日立製作所 Semiconductor cooling device
US6703392B2 (en) 2000-03-14 2004-03-09 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisoquinoline derivatives
AU2005250077B2 (en) 2004-03-01 2011-06-09 Idorsia Pharmaceuticals Ltd Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
EA201990399A1 (en) * 2016-07-29 2019-07-31 Суновион Фармасьютикалз, Инк. COMPOUNDS, COMPOSITIONS AND THEIR APPLICATION
CN116283877A (en) 2016-07-29 2023-06-23 赛诺维信制药公司 Compounds, compositions and uses thereof
EA202090414A1 (en) 2017-08-02 2020-05-28 Суновион Фармасьютикалз Инк. COMPOUNDS AND THEIR APPLICATION
AU2020236225A1 (en) 2019-03-14 2021-09-16 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0359537B1 (en) * 1988-09-16 1996-06-26 Beecham Group Plc Benzopyran derivatives with antihypertensive activity
FR2670780B1 (en) * 1990-12-20 1993-07-09 Synthelabo DERIVATIVES OF 4- (ACYLAMINO) BENZOPYRANS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
FR2687401B1 (en) * 1992-02-18 1994-05-20 Meram Laboratoires 1,4-DIALKYLPIPERAZINE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
US5374643A (en) * 1992-09-11 1994-12-20 E. R. Squibb & Sons, Inc. Aryl urea (thiourea) and cyanoguanidine derivatives
US5807897A (en) * 1996-03-01 1998-09-15 Zeneca Limited Aminotetralin derivative and compositions and method of use thereof
AU717431B2 (en) * 1996-07-01 2000-03-23 Schering Corporation Muscarinic antagonists
GB9726736D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Chemical compounds
GB9801812D0 (en) * 1998-01-29 1998-03-25 Zeneca Ltd Chemical compounds
GB9900078D0 (en) * 1999-01-05 1999-02-24 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
EP1192146A1 (en) 2002-04-03
JP2003502415A (en) 2003-01-21
WO2000078742A1 (en) 2000-12-28
AU5414100A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
GB9907658D0 (en) Chemical compounds
GB9902461D0 (en) Chemical compounds
GB9909409D0 (en) Chemical compounds
GB9903861D0 (en) Chemical compounds
GB9910104D0 (en) Chemical compounds
GB9914025D0 (en) Chemical compounds
GB9910110D0 (en) Chemical compounds
GB9900078D0 (en) Chemical compounds
GB9914015D0 (en) Chemical compounds
GB9914026D0 (en) Chemical compounds
GB9914024D0 (en) Chemical compounds
GB9910394D0 (en) Chemical compounds
GB9908355D0 (en) Chemical compounds
GB9914022D0 (en) Chemical compounds
GB9910419D0 (en) Chemical compounds
GB9907656D0 (en) Chemical compounds
GB9909582D0 (en) Chemical compounds
GB9903857D0 (en) Chemical compounds
GB9903859D0 (en) Chemical compounds
GB9903532D0 (en) Chemical compounds
GB9910396D0 (en) Chemical compounds
GB9903860D0 (en) Chemical compounds
GB9910405D0 (en) Chemical compounds
GB9907657D0 (en) Chemical compounds
GB0001663D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)